Determination of residual solvents in bulk pharmaceuticals by thermal desorption/gas chromatography/mass spectrometry

Thermal desorption (TD) techniques followed by capillary GC/MS were applied for the analysis of residual solvents in bulk pharmaceuticals. Solvents desorbed from samples by heating were cryofocused at the head of a capillary column prior to GC/MS analysis. This method requires a very small amount of sample and no sample pretreatment. Desorption temperature was set at the point about 20 degrees C higher than the melting point of each sample individually. The relative standard deviations of this method tested by performing six consecutive analyses of 8 different samples were 1.1 to 3.1%, and analytical results of residual solvents were in agreement with those obtained by direct injection of N,N-dimethylformamide solution of the samples into the GC. This novel TD/GC/MS method was demonstrated to be very useful for the identification and quantification of residual solvents in bulk pharmaceuticals.     

Analysis of class 1 residual solvents in pharmaceuticals using headspace-programmed temperature vaporization-fast gas chromatography-mass spectrometry

A sensitive method is presented for the fast screening and determination of residual class 1 solvents (1,1-dichloroethene, 1,2-dichloroethane, 1,1,1-trichloroethane, carbon tetrachloride and benzene) in pharmaceutical products. The applicability of a headspace (HS) autosampler in combination with GC equipped with a programmed temperature vaporizer (PTV) and a MS detector is explored. Different injection techniques were compared. The benefits of using solvent vent injection instead of split or splitless-hot injection for the measurement of volatile compounds are shown: better peak shapes, better signal-to-noise ratios, and hence better detection limits. The proposed method is extremely sensitive. The limits of detection ranged from 4.9 ppt (benzene) to 7.9 ppt (1,2-dichloroethane) and precision (measured as the relative standard deviation) was equal to or lower than 12% in all cases. The method was applied to the determination of residual solvents in nine different pharmaceutical products. The analytical performance of the method shows that it is appropriate for the determination of residual class 1 solvents and has much lower detection limits than the concentration limits proposed by the International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use. The proposed method achieves a clear improvement in sensitivity with respect to conventional headspace methods due to the use of the PTV.     

Fast capillary GC using a low thermal mass column oven for the determination of residual solvents in pharmaceuticals

A low thermal mass column oven was used for fast capillary GC analysis (high throughput) of residual solvents in pharmaceutical products. A dedicated capillary column, 20 m L x 180 microm ID x 1 microm DB-624 was programmed from 35 degrees C (30 s) to 150 degrees C at 100 degrees C/min and to 250 degrees C (30 s) at 200 degrees C/min, resulting in a total GC cycle time of less than 4 min. Complete separation of a target 20-component mixture was achieved, while method performance in terms of repeatability, sensitivity, and linearity was maintained in comparison to the generic method currently applied in our laboratories.     

Establishment of a knowledge base for identification of residual solvents in pharmaceuticals

A knowledge base for identification of residual solvents in pharmaceuticals has been established using gas chromatograph-mass spectrometry (GC-MS) and gas chromatograph-Fourier transform infrared spectrometry (GC-FTIR). Sixty solvents were studied according to the guideline for residual solvents regulated by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The standard mass spectra library, the limit of detection (LOD) mass spectra library, the standard vapor-phase infrared spectra library, and the limit of detection (LOD) vapor-phase infrared spectra library were established and constituted the knowledge base. Using the knowledge base, the problem of qualitation, which was the difficulty of determining residual solvents, can be resolved.     

Determination of residual solvents in pharmaceuticals by thermal desorption-GC/MS.

A novel method for the determination of residual solvents in pharmaceuticals by thermal desorption (TD)-GC/MS has been established. A programmed temperature pyrolyzer (double shot pyrolyzer) is applied for the TD. This method does not require any sample pretreatment and allows very small amounts of the sample. Directly desorbed solvents from intact pharmaceuticals (ca. 1 mg) in the desorption cup (5 mm x 3.8 mm i.d.) were cryofocused at the head of a capillary column prior to a GC/MS analysis. The desorption temperature was set at a point about 20 degrees C higher than the melting point of each sample individually, and held for 3 min. The analytical results using 7 different pharmaceuticals were in agreement with those obtained by direct injection (DI) of the solution, followed by USP XXIII. This proposed TD-GC/MS method was demonstrated to be very useful for the identification and quantification of residual solvents. Furthermore, this method was simple, allowed rapid analysis and gave good repeatability.     

Automated gas chromatographic method for the determination of residual solvents in bulk pharmaceuticals

A generalized gas chromatographic method is described for the determination of a wide variety of residual solvents and other volatile impurities in bulk pharmaceuticals. The method employs a highly selective graphitized carbon-black stationary phase, which is demonstrated to retain compounds on the basis of a linear combination of their boiling points and molecular volumes (i.e., molecular weight divided by density). An autosampler is utilized to optimize injection precision and to provide for high sample throughput. Analytical data from replicate determinations of seven representative compounds are reported, and it is shown that calibration of the chromatographic systems against external standards produces comparable results to those obtained by standard addition techniques.     

Preliminary identification and quantification of residual solvents in pharmaceuticals using the parallel dual-column system

A database for preliminary identification and quantification of residual solvents in pharmaceuticals has been established using the parallel dual-column system. Two columns with different polarities, SPB-1 and HP-INNOWAX, connected with a 'Y' splitter, constituted the dual pathways system. Fifty-two solvents were studied according to the guidelines for residual solvents regulated by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) on this system. Through a single run, preliminary identification and quantification can be performed using the database. An important advantage of the database is that the residual solvents in the pharmaceuticals can be prescreened without using reference organic solvents.     

Analysis of OSPAR priority pharmaceuticals using high-performance liquid chromatography-electrospray ionisation tandem mass spectrometry

The occurrence and potential adverse effects of pharmaceutical compounds in the aquatic environment have received much scientific interest. Presented are analytical methodologies for the determination of 10 of the pharmaceuticals listed on the Oslo and Paris Commission for the protection of the Marine Environment of the North East Atlantic (OSPAR) hazardous substances website. In addition to these 10 substances, the chemical fluoxetine (Prozac) was also investigated. The performance characteristics of a combined solid phase extraction (SPE) isolation and high-performance liquid chromatography-electrospray ionisation tandem mass spectrometry (HPLC-ESI-MS/MS) procedure have been determined. Extraction efficiencies were obtained for a variety of SPE sorbents, following this initial investigation. Strata-X (Phenomenex, UK) was selected for further development. The extraction method performed satisfactorily for the majority of the 11 compounds analysed, with recoveries of over 60% for most of the compounds and relative standard deviations of between 4 and 13%. The recoveries of chloroquine and closantel were below 50% but the method provides semi-quantitative information regarding the occurrence of these compounds. Separation of the analytes was made using a C18 Luna analytical column (Phenomenex, UK) and mass spectra were obtained using an ion trap mass spectrometer operated in both positive and negative electrospray ionisation modes. Limits of detection for all compounds ranged from 1 to 20 ng/l, making the method suitable for low level environmental analysis. Of the selected surface water and treated sewage effluent samples (n = 6) analysed, chlorpromazine, fluoxetine and miconazole were detected in concentrations ranging from 7 to 34 ng/l. The chemicals determined using this procedure fall into a variety of pharmaceutical classes including antipsychotics and tranquilisers resulting in an analytical method that contains compounds from diverse chemical classes.     

Dispersive liquid-liquid microextraction combined with gas chromatography for extraction and determination of class 1 residual solvents in pharmaceuticals

The present study reports a new method for analyzing class 1 residual solvents (RSs), 1,1-dichloroethene (1,1-DCE), 1,2-dichloroethane (1,2-DCE), 1,1,1-trichloroethane (1,1,1-TCE), carbon tetrachloride (CT), and benzene (Bz), in pharmaceutical products using dispersive liquid-liquid microextraction (DLLME) combined with gas chromatography-flame ionization detection (GC-FID). Unlike common DLLME methods, solvents of high boiling point were selected as dispersive and extraction solvents in order to prevent their chromatographic peaks from overlapping with those of analytes that have short retention times. Therefore N,N-dimethyl formamide (DMF) and 1,2-dibromoethane (1,2-DBE) were chosen as dispersive and extraction solvents, respectively. Analytical parameters of the proposed method were determined and good linearities and broad linear ranges (LRs) were obtained. Taking 500 mg samples, limit of detections for the tested pharmaceuticals were obtained as 0.11, 0.03, 0.05, 0.05, and 0.006 μg g(-1) for CT, 1,1-DCE, 1,2-DCE, 1,1,1-TCE, and Bz, respectively, which are considerably much lower than their permissible limits in pharmaceuticals.     

Determination of pharmaceuticals in wastewaters using solid-phase extraction-liquid chromatography-tandem mass spectrometry

Four different commercial sorbents for solid-phase extraction have been evaluated for the extraction of a group of acidic pharmaceuticals in terms of selectivity and capacity: Oasis hydrophilic-lipophilic balance (HLB), Oasis MAX (strong anion exchange), Oasis WAX (weak anion exchange) and a commercial available molecularly imprinted polymer specific for non-steroidal anti-inflammatory drugs. Among the sorbents studied, molecularly imprinted polymer proved to be very effective in the reduction of matrix interferences and the selective extraction of acidic pharmaceuticals, such as salicylic acid, ibuprofen, fenoprofen, diclofenac and naproxen, among others, from effluent wastewater samples. Moreover, molecularly imprinted solid-phase extraction protocol was applied to liquid chromatography coupled to tandem mass spectrometry (MS/MS) with the purpose of evaluating the clean-up effect on ion suppression/enhancement when the complexity of the samples increases and a reduction of this effect was observed. Molecularly imprinted solid-phase extraction followed by liquid chromatography coupled to ultraviolet detection and liquid chromatography coupled to tandem mass spectrometry validation methodologies with effluent wastewaters were developed, obtaining recoveries between 70 and 85% and limits of detection at low levels of μg/L (0.15-1 μg/L) and ng/L (0.5-2 ng/L), respectively. The final application of molecularly imprinted solid-phase extraction and liquid chromatography coupled to MS/MS detection showed the presence of acidic pharmaceuticals studied in this work in effluent wastewaters (相似文献   

Application of the solvation parameter model in method development for analysis of residual solvents in pharmaceuticals

The solvation parameter model was applied in the development of a method for the analysis of residual solvents in pharmaceuticals. The interactions between organic solvents and six different stationary phases were studied using gas chromatography. The retention times of the organic solvents on these columns could be predicted under isothermal or temperature-programmed conditions using the established solvation parameter models. The predicted retention times helped in column selection and in optimizing chromatographic conditions during method development, and will form the basis for the development of a computer-aided method.     

Analysis of BTEX and chlorinated solvents in meconium by headspace-solid-phase microextraction gas chromatography coupled with mass spectrometry

Meconium is the earliest stool of newborns, and is a complex matrix that reflects the degree of exposure of the fetus to xenobiotics. To investigate fetal exposure to volatile organic compounds, an analytical method was developed to identify and quantify BTEX (benzene, toluene, ethylbenzene, and o,m,p-xylene) and two chlorinated solvents (trichloroethylene and tetrachloroethylene) in meconium. Headspace-solid-phase microextraction coupled with gas chromatography–mass spectrometry was selected because it is simple, sensitive, can be automated, and requires no extensive sample preparation. Several extraction variables were optimized (fiber type, incubation time, temperature of fiber, and use of salt). Because meconium is a complex matrix, quantification by SPME was considered carefully because of potential interference, for example competitive adsorption. Calibration in water was compared with calibration in meconium using external and internal methods (with isotope-labeled compounds). In meconium, limits of quantification were determined to be in the range 0.064–0.096 ng g^?1 for the investigated compounds. All target compounds were determined in “real-case” meconium samples.     

Quantitative 252Cf plasma desorption mass spectrometry for pharmaceuticals: A new approach to coupling liquid chromatography with mass spectrometry

A ²⁵²Cf plasma desorption mass spectrometer has been set up to analyse thin layers of non-volatile organic samples. Molecular and fragment ions were produced and their mass was determined by a time-of-flight measurement. A novel interface combines a high-performance liquid chromatograph with the ²⁵²Cf plasma desorption mass spectrometer in a twofold way: introducing the effluent continuously through a capillary inlet in the on-line liquid chromatography mass spectrometry mode or transferring already prepared samples through a vacuum lock into the mass spectrometer in the off-line liquid chromatography+mass spectrometry mode. The off-line mode has been applied for the quantitative analysis of pharmaceuticals in blood using stable isotope labelled standards.     

Multi-residue analysis of pharmaceuticals in wastewater by ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry

In this work, a new multi-residue method using ultra-performance liquid chromatography (UPLC) quadrupole-time-of-flight mass spectrometry (Q-TOF-MS) was developed for screening and confirmation of 29 pharmaceutical compounds belonging to different therapeutical classes: analgesics and antiinflammatories, lipid regulating agents cholesterol lowering statin agents, psychiatric drugs, anti ulcer agents, histamine H2 receptor antagonist, antibiotics and beta-blockers. UPLC uses columns packed with 1.7 microm particles and enables elution of sample components in much narrower, more concentrated bands, resulting in better chromatographic resolution and increased peak height. The typical peak width was 5-10s at base, permitting very good separation of all compounds in 10 min, which represented an approximate three-fold reduction in the analysis time in comparison to conventional high-performance liquid chromatography (HPLC). Unequivocal identification of target pharmaceutical compounds was based on accurate mass measurement of the molecular ions in the TOF mode and by performing collision induced dissociation (CID) in the Q-TOF mode in order to generate accurate mass measurement of the product ions. Using lock mass correction the accurate masses calculated for the product ions deviated from the theoretical masses by 0.2 to 1.3 mDa (root mean square (RMS) value=0.67) and 0.7-6.4 ppm (RMS=3.53), respectively. Quantitation was carried out working in the TOF mode using the narrow window extracted ion chromatograms (nwXICs) of each compound (extracted using a 20 mDa window) yielding relative standard deviation (RSD) from 0.5 to 5.3% (run-to-run) and from 2.1 to 9.1% (day-to-day) and instrumental detection limits (IDLs) from 1 to 200 pg. Analysis of wastewater treatment plant (WWTP) samples gave method detection limits (MDLs) ranging from 10 to 500 ng/L. The UPLC-Q-TOF method was successfully applied to analyze pharmaceutical residues in WWTP samples.     

Extraction and analysis of pharmaceuticals in polluted sediment using liquid chromatography mass spectrometry

A multi-residue method for the extraction and clean-up of sediment samples was developed for the analysis of pharmaceutical residues. Sediment samples were collected in the proximity of sewage water plant in Stockholm, Sweden. Target analytes were the basic β-blocker propranolol, the neutral neuroleptic carbamazepine and the acidic anticoagulant warfarin, the painkiller diclofenac and the lipid regulator gemfibrozil. The extraction solvent was optimised with regard to pH and organic modifer. Extraction and clean up were performed with liquid-liquid extraction and ultra-sonication followed by solid-phase extraction. One extraction solvent, containing acetone/McIlvaine buffer pH4, provided satisfactory extraction for all substances. LC/MSMS in the MRM mode was used for determination. The recoveries of the extraction and clean-up steps were 60–75% (±2–8%) and LOQs were in the range 0.4–8?ng/g sediment (dry weight). The pharmaceuticals found in the sediment samples were propranolol and carbamazepine, representing substances with basic and neutral properties. Additionally, the samples were analysed with LC/QTOF for verification with the use of accurate mass measurement in the full-scan mode. Pharmaceuticals not represented in the original method were looked for. Non-target pharmaceuticals found using the LC/QTOF system were the basic β-blocker metoprolol and the acidic painkiller naproxen.     

Analysis of organic solvents in printing inks by headspace gas chromatography – mass spectrometry

Static headspace analysis by gas chromatography has been found to be a suitable method for the analysis of organic solvents in printing inks. Experimental conditions for the analysis have been optimized, and the accuracy and relative standard deviation of the method has been determined. The solvent content of 29 printing inks has been measured.     

Drug matrix effect on the determination of residual solvents in bulk pharmaceuticals by wide-bore capillary gas chromatography.

A wide-bore capillary gas chromatographic method has been developed to study the drug matrix effect on the determination of residual solvents in bulk pharmaceuticals. A selective method is achieved on a Restek wide-bore (0.53-mm i.d. x 30 m) open-tubular fused-silica column coated with a 5-micron film of 95% dimethyl-5% diphenyl polysiloxane protected by a phenyl-methyl siloxane deactivated, uncoated fused-silica guard column. Utilizing this method, several common process solvents in weakly acidic, weakly basic, and neutral drug matrices are evaluated by recovery and linearity studies to show whether or not a drug matrix effect exists in their determination.     

Desorption electrospray ionization mass spectrometry for the analysis of pharmaceuticals and metabolites

The performance of desorption electrospray ionization (DESI) in the analysis of a group of pharmaceuticals and their glucuronic acid conjugates is reported. The suitability of different sprayer solvents and different surfaces was examined. In the positive ion mode, water/methanol/trifluoroacetic acid performed best, whereas, in the negative ion mode, water/methanol/ammonium hydroxide was found to be the most suitable spray solvent. Of the surfaces investigated, polymethylmethacrylate (PMMA) was found to give the best performance in terms of sensitivity. Spray solution flow rate and the distance of the sprayer tip from the surface were also found to have significant effects on the signal intensity. Analytes with basic groups efficiently formed the corresponding protonated molecules in the positive ion mode, whereas acidic analytes, such as the glucuronic acid conjugates, formed intense signals due to the deprotonated molecules in the negative ion mode. Ionization of neutral compounds was less efficient and in many cases it was achieved through adduct formation with simple anions or cations.     

Determination of residual pharmaceuticals in edible animal tissues by continuous solid-phase extraction and gas chromatography-mass spectrometry

A sensitive, reliable method using continuous solid-phase extraction and gas chromatography-mass spectrometry was developed for the simultaneous determination of twenty pharmaceuticals including antibacterials, anti-epileptics, antiseptics, β-blockers, lipid regulators, hormones and non-steroidal anti-inflammatories at trace levels in edible animal tissues. The procedure involves deproteination and delipidation of samples by precipitation/centrifugation/filtration, followed by sample enrichment and cleanup by continuous solid-phase extraction. The proposed method was validated with quite good analytical results including low limits of detections (0.4-2.7 ng kg⁻¹ for 2 g of sample) and good linearity (r² > 0.995) throughout the studied concentration ranges. In addition, the method is quite accurate (recoveries ranged from 92 to 101%) and precise (within-day and between-day RSD values were less than 7%), which allows the determination of residual pharmaceuticals in tissues from agricultural farm and fish hatchery animals (pig, veal, lamb and chicken muscle, kidney and liver; and salmon, sea bass and sole flesh). The analytes most frequently found in the studied samples were the hormones estrone and 17β-estradiol, and the antibacterials florfenicol and pyrimethamine.